Compare Johnson & Johnson (JNJ) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Logitech International SA — how do they compare? Johnson & Johnson trades at $259.54 (market cap $618.09B), while Logitech International SA trades at $99.39 (market cap $14.46B). The key difference: Johnson & Johnson is far larger — about 42.7× Logitech International SA's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Logitech International SA for 92 Days on average.
| JNJ | LOGI | |
|---|---|---|
Market Cap | $618.09B | $14.46B |
Volume | 6,050,983 | 349,547 |
Sector | Health | Technology |
52-Week High | $278.43 | $126.69 |
52-Week Low | $186.00 | $85.84 |
Typical Hold Time | 129 Days | 92 Days |
Enterprise Value | $646.37B | $12.79B |
Dividend Yield | 2.09% | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $258.45, up 1.44% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and robust cash flow. Analyst consensus is bullish with a $286.53 price target, though technical indicators show resistance near $260. Recent news highlights pipeline strength including Icotyde's potential $4.5B peak sales.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and competitive pressures. The stock presents value near current levels with 10.7% upside to consensus target, though technical weakness suggests potential near-term consolidation. Long-term growth drivers include oncology portfolio and Ottava surgical system development.
Logitech (LOGI) trades at $100.70, down 1.45% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $107.00. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $1.85 surpassing the $1.26 estimate. The company maintains strong profitability, including a 16.28% net income margin and 35.29% ROE, and has announced new product launches like the Zone Vibe Pro headset and a partnership with SEGA.
The outlook is supported by solid fundamentals and positive product news, but risks include competitive pressures and macroeconomic sensitivity. Analyst sentiment is mixed, with a Hold consensus, suggesting cautious optimism. Upside potential exists if the company continues its earnings beat streak and navigates supply chain challenges effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
